PD-L1 expression and immune profiling cannot predict osimertinib efficacy in lung cancer with EGFR T790 M mutation: A translational studyChing‐Yao Yang, Chong‐Jen Yu, Chao‐Chi Ho et al.|Journal of the Formosan Medical Association|2024Cited by 5